Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
1 Day SUM -0.59% DJIA -0.26% S&P Mid Cap 400 -0.20% Health Care/Life Sciences -0.08% ...
1 Day SUM -0.20% DJIA -0.26% S&P Mid Cap 400 -0.20% Health Care/Life Sciences -0.08% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results